Ryan Cawood

1.0k total citations
23 papers, 484 citations indexed

About

Ryan Cawood is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Ryan Cawood has authored 23 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 14 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Ryan Cawood's work include Virus-based gene therapy research (15 papers), RNA Interference and Gene Delivery (7 papers) and CAR-T cell therapy research (6 papers). Ryan Cawood is often cited by papers focused on Virus-based gene therapy research (15 papers), RNA Interference and Gene Delivery (7 papers) and CAR-T cell therapy research (6 papers). Ryan Cawood collaborates with scholars based in United Kingdom, Czechia and Netherlands. Ryan Cawood's co-authors include Leonard W. Seymour, Hannah H. Chen, Miriam Bazán‐Peregrino, Nico van Rooijen, Wendy Bruins, Kerry D. Fisher, Mark L. Reed, Sally M. Harrison, Brian K. Dove and Julian A. Hiscox and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Ryan Cawood

22 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan Cawood United Kingdom	13	270	240	99	80	55	23	484
Christopher Y. Chen United States	13	286 1.1×	264 1.1×	107 1.1×	84 1.1×	52 0.9×	20	464
Oliwia Andries Belgium	8	725 2.7×	192 0.8×	58 0.6×	121 1.5×	167 3.0×	8	838
Anssi J. Mähönen Finland	14	396 1.5×	187 0.8×	43 0.4×	43 0.5×	26 0.5×	17	510
Sandesh Subramanya United States	14	474 1.8×	114 0.5×	97 1.0×	89 1.1×	179 3.3×	19	819
Ana F. Rodrigues Portugal	14	320 1.2×	255 1.1×	62 0.6×	84 1.1×	53 1.0×	26	466
Viraj Mane United States	12	362 1.3×	361 1.5×	99 1.0×	120 1.5×	156 2.8×	15	672
Lalita Wadhwa United States	8	176 0.7×	130 0.5×	69 0.7×	60 0.8×	21 0.4×	21	370
Alexandre Lima de Andrade Brazil	14	249 0.9×	96 0.4×	43 0.4×	29 0.4×	40 0.7×	59	591
Szu‐Ting Chou United States	9	250 0.9×	56 0.2×	31 0.3×	150 1.9×	49 0.9×	14	457

Countries citing papers authored by Ryan Cawood

Since Specialization

Citations

This map shows the geographic impact of Ryan Cawood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Cawood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Cawood more than expected).

Fields of papers citing papers by Ryan Cawood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Cawood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Cawood. The network helps show where Ryan Cawood may publish in the future.

Co-authorship network of co-authors of Ryan Cawood

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Cawood. A scholar is included among the top collaborators of Ryan Cawood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Cawood. Ryan Cawood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Su, Weiheng, Leonard W. Seymour, & Ryan Cawood. (2023). AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes. Scientific Reports. 13(1). 21670–21670. 8 indexed citations

Su, Weiheng, et al.. (2022). Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination. Nature Communications. 13(1). 1182–1182. 26 indexed citations

Robertson, N.J., et al.. (2020). Development of a novel mammalian display system for selection of antibodies against membrane proteins. Journal of Biological Chemistry. 295(52). 18436–18448. 19 indexed citations

Cawood, Ryan. (2020). Redefining AAV Manufacturing: The Time Is Now. Genetic Engineering & Biotechnology News. 40(10). 68–70. 1 indexed citations

Christianson, John C., Brian Champion, Adrienne W. Paton, et al.. (2019). Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation. Molecular Therapy — Oncolytics. 15. 117–130. 10 indexed citations

Hills, Thomas, et al.. (2016). A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation. PLoS ONE. 11(11). e0166383–e0166383. 13 indexed citations

Mo, Steven, Robert Carlisle, Richard Laga, et al.. (2015). Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours. Journal of Controlled Release. 210. 10–18. 23 indexed citations

Kueberuwa, Gray, et al.. (2014). Tissue-Specific Attenuation of Oncolytic Sindbis Virus Without Compromised Genetic Stability. Human Gene Therapy Methods. 25(2). 154–165. 9 indexed citations

Carlisle, Robert, Steven Mo, Rachel Myers, et al.. (2013). Increased Adenovirus density for increased ultrasound-mediated delivery to tumors. Human Gene Therapy. 24. 1 indexed citations

10.

Cawood, Ryan, et al.. (2012). Recombinant viral vaccines for cancer. Trends in Molecular Medicine. 18(9). 564–574. 30 indexed citations

11.

Cawood, Ryan, et al.. (2011). Virotherapy – cancer targeted pharmacology. Drug Discovery Today. 17(5-6). 215–220. 10 indexed citations

12.

Cawood, Ryan, et al.. (2011). MicroRNA Controlled Adenovirus Mediates Anti-Cancer Efficacy without Affecting Endogenous MicroRNA Activity. PLoS ONE. 6(1). e16152–e16152. 33 indexed citations

13.

Seki, Takahiro, et al.. (2011). Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway. Journal of Controlled Release. 156(3). 381–389. 45 indexed citations

14.

Cawood, Ryan, Leonard W. Seymour, & Sandy Wong. (2010). MicroRNA Regulation of Adenovirus Afford Control of Oncolytic Activity Without Changing Endogenous MicroRNA Levels. Human Gene Therapy. 21(10). 1376–1376.

15.

Chen, Hannah H., Ryan Cawood, Yasser M. El‐Sherbiny, et al.. (2010). Active Adenoviral Vascular Penetration by Targeted Formation of Heterocellular Endothelial–epithelial Syncytia. Molecular Therapy. 19(1). 67–75. 17 indexed citations

16.

Cawood, Ryan, et al.. (2009). Use of Tissue-Specific MicroRNA to Control Pathology of Wild-Type Adenovirus without Attenuation of Its Ability to Kill Cancer Cells. PLoS Pathogens. 5(5). e1000440–e1000440. 112 indexed citations

17.

Chen, Hannah H., Ryan Cawood, & Leonard W. Seymour. (2008). Toward more effective gene delivery. Genome Biology. 9(1). 301–301. 3 indexed citations

18.

Cawood, Ryan, Sally M. Harrison, Brian K. Dove, Mark L. Reed, & Julian A. Hiscox. (2007). Cell Cycle Dependent Nucleolar Localization of the Coronavirus Nucleocapsid Protein. Cell Cycle. 6(7). 863–867. 43 indexed citations

19.

Bruins, Wendy & Ryan Cawood. (1991). Blast injuries of the ear as a result of the Peterborough lorry explosion: 22 March 1989. The Journal of Laryngology & Otology. 105(11). 890–895. 29 indexed citations

20.

Cawood, Ryan, et al.. (1982). Achalasia: presentation with stridor and a new form of treatment.. BMJ. 285(6356). 1704.1–1704. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact